Akili Interactive, a company in the field of digital medicine that focuses on developing cognitive treatments using innovative technologies has recently announced its plans to go public. This will be achieved through a merger, with Social Capital Suvretta Holdings Corp., which's a special purpose acquisition company.
Omada Health Inc. introduced two resources designed to support individuals, with chronic conditions by providing personalized care options and reducing their financial burden.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5540
Published Date: Jan 16, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growth of the digiceuticals market is being driven by several factors, such as the rising popularity of digital health technologies, the increasing need for personalized healthcare, the increasing prevalence of chronic diseases, and the rising cost of traditional healthcare.
The market size of digiceuticals is anticipated to attain a CAGR of 33% over the forecast period, i.e., 2024-2036.
The major players in the market are Pear therapeutics Inc., Akili Interactive Labs, Inc., Chrono Therapeutics Inc., Click Therapeutics, Omada Health, Canary Health, Inc., Glooko, Inc., Propeller helath, Welldoc, Voluntis, and others.
The smartphone segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.